Megan is a prominent corporate and securities attorney who deftly steers public companies through capital-raising transactions, SEC reporting obligations, and mergers and acquisitions. She applies knowledge she gained during an earlier in-house role with a laboratory and analytical instrument maker to ably advise life sciences and other clients on corporate governance and SEC compliance matters.
Megan is a member of the Firm's Policy Committee and Co-chair of the Securities & Capital Markets Practice Group. She concentrates her practice on providing counsel to public companies with respect to public and private equity financings, merger and acquisition transactions, and compliance and disclosure obligations under the Securities Exchange Act of 1934.
Megan frequently advises clients on corporate governance matters, including compliance with the Sarbanes-Oxley Act of 2002. She also has extensive experience with tender offers, exchange offers, and going-private transactions.
Megan frequently speaks at conferences on securities offerings, corporate governance, and compliance matters, including at Massachusetts Continuing Legal Education (MCLE) panels and industry meetings.
Articles in the National Law Review database by Megan N. Gates